Skip to content

Effects of Exercise During Pregnancy on the Long-term Metabolic Health of Mothers and Their Offspring

Long-Term Effects of Exercise During Pregnancy on the Metabolic Health of Mothers and Their Offspring: An 8- to 10-year Follow-Up Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07435857
Enrollment
221
Registered
2026-02-27
Start date
2024-06-01
Completion date
2024-11-15
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Health

Keywords

Exercise, Obesity, Follow-up, Metabolism, Maternal-offspring

Brief summary

The aim of this study was to assess the long-term metabolic effects of gestational exercise on overweight and obese women and their offspring 8-10 years post-intervention.

Detailed description

We conducted a follow-up study of a randomized controlled trial (RCT) in which the impact of prenatal exercise on the incidence of gestational diabetes mellitus (GDM) was investigated. Mother-offspring pairs underwent comprehensive metabolic evaluations, including anthropometric measurements (weight, skinfold thickness, and body composition), blood pressure assessment, oral glucose tolerance tests (OGTTs), insulin release tests (IRTs), and lipid profiling.

Interventions

BEHAVIORALexercise

The present study is a prospective follow-up of a randomized controlled trial (RCT) that was conducted in the Department of Obstetrics and Gynecology, Peking University First Hospital, from December 2014 to April 2017. In this RCT, 300 obese/overweight pregnant women (prepregnancy BMI ≥24 kg/m²) at \<12+6 weeks of gestation were randomized to exercise (n=150) and control groups (n=150), and the efficacy of regular exercise in early pregnancy to prevent GDM among overweight/obese pregnant Chinese women was investigated. The patients allocated to the exercise group were assigned to a cycling program (3 times per week, at least 30 min/session, rating of perceived exertion 12-14); the program was initiated within 3 days of randomization and continued until 37 weeks of gestation. The patients in the control group maintained their usual daily activities. The original RCT has been reported previously (Wang, C.Am. J. Obstet. Gynecol. 2017, 216 (4), 340-351.)

Sponsors

Peking University First Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- 132 mothers in the exercise group and 133 mothers in the control group in the previous RCT trial who had OGTT results and their offsprings were eligible for follow-up

Exclusion criteria

\- The criteria for exclusion from the follow-up study included loss to follow-up, refusal to participate, or major illness (acute lymphoblastic leukemia) of the mother or the child.

Design outcomes

Primary

MeasureTime frameDescription
OGTT8-10 years75-g oral glucose tolerance test (0h,2h,mmol/L)

Secondary

MeasureTime frameDescription
BMI8-10 yearsweight in kilograms, height in meters, and weight and height will be combined to report BMI in kg/m2
anthropometric measures8-10 yearsanthropometric measurements include waist circumference and skinfold thickness (centimeters) using skinfold caliper. Additionally,And use a body composition analyzer to measure body fat content and distribution ( The fat mass \[kg\]; fat percentage \[%\]; visceral fat area \[cm2\]; and lean mass \[kg\] were determined using bioimpedance analysis).
insulin resistance8-10 yearsplasma insulin levels were measured using electrochemiluminescence, and insulin resistance was calculated via the HOMA equation (fasting plasma insulin concentration (μIU/mL) × fasting glucose concentration (mmol/L)/22.5).
lipid profile8-10 yearsfasting lipid profiles, including total cholesterol (TCHO), triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured via the cholesterol oxidase method (mmol/L)

Countries

China

Contacts

PRINCIPAL_INVESTIGATORChen Wang

Peking University Frist hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026